ProQR Therapeutics Announces Key Updates During Virtual Event; Emphasizes Expansion Of Pipeline With Two New Programs And Leading RNA Editing Program On Track For Target Engagement Data

Benzinga Newsdesk www.benzinga.com Positive 93.1%

Neg 0% Neu 0% Pos 93.1%

Comments

No comments yet. Be the first!